Formfactor Inc: Form 10-K for the period ended Dec 27, 2014
Filed with the SEC on Mar 6, 2015 and accepted by EDGAR at Mar 6, 2015, 16:32 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-09-28 to 2014-12-27 | $71.3m | us-gaap:SalesRevenueNet |
| Revenue | 12 months2013-12-29 to 2014-12-27 | $268.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-09-28 to 2014-12-27 | $50.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 12 months2013-12-29 to 2014-12-27 | $191.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2014-09-28 to 2014-12-27 | $20.9m | us-gaap:GrossProfit |
| Gross profit | 12 months2013-12-29 to 2014-12-27 | $77.4m | us-gaap:GrossProfit |
| Research and development | 3 months2014-09-28 to 2014-12-27 | $10.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 12 months2013-12-29 to 2014-12-27 | $42.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-09-28 to 2014-12-27 | $12.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 12 months2013-12-29 to 2014-12-27 | $51.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-09-28 to 2014-12-27 | −$3.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2013-12-29 to 2014-12-27 | −$20.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-09-28 to 2014-12-27 | −$1.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 12 months2013-12-29 to 2014-12-27 | −$910.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-09-28 to 2014-12-27 | −$1.9m | us-gaap:NetIncomeLoss |
| Net income | 12 months2013-12-29 to 2014-12-27 | −$19.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2013-12-29 to 2014-12-27 | −$0.34 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2013-12-29 to 2014-12-27 | $17.7m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2013-12-29 to 2014-12-27 | $5.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-12-27 | $113.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-27 | $244.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-27 | $344.2m | us-gaap:Assets |
| Current liabilities | At period end2014-12-27 | $47.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-27 | $54.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-12-27 | $289.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001039399-15-000005. Last ingested by Listed: Nov 13, 2026, 15:19 ET. Listed shows no prices and gives no investment advice.